Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 2,607 | 2,704 | 2,142 | 1,746 | 1,541 |
| Gross Profit | 2,607 | 2,704 | 2,142 | 1,746 | 1,541 |
| Operating Expenses | 6,268 | 5,884 | 4,816 | 3,757 | 2,925 |
| Operating Income | -3,661 | -3,180 | -2,674 | -2,011 | -1,384 |
| Interest Expense | 0 | 0 | 0 | 0 | 131 |
| Other Income | -22,692 | -20,664 | -13,601 | -9,428 | -9,041 |
| Pre-tax Income | -26,353 | -23,844 | -16,275 | -11,439 | -10,556 |
| Net Income Continuous | -26,353 | -23,844 | -16,275 | -11,439 | -10,556 |
| Net Income | $-26,353 | $-23,844 | $-16,275 | $-11,439 | $-10,556 |
| EBITDA(a) | $-3,661 | $-3,180 | $-2,674 | $-2,011 | $-1,384 |